Teknova to Report Fourth Quarter and Full Year 2022 Financial Results on March 15, 2023

Rhea-AI Summary

Alpha Teknova (Nasdaq: TKNO) announced it will report its financial results for Q4 and full year 2022 on March 15, 2023, after market close. The company specializes in critical reagents for life sciences, enhancing the development of therapies and diagnostics. A webcast and conference call will follow at 5:00 p.m. ET, accessible through their Investor Relations page. The event's replay will be available two hours post-event.

Positive

• Announcement of upcoming Q4 and full year 2022 financial results.
• Engagement with investors via webcast and conference call.

Negative

• None.

HOLLISTER, Calif., Feb. 23, 2023 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the research, discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics, today announced that the Company will report its financial results for the fourth quarter and full year ended December 31, 2022, on Wednesday, March 15, 2023, following the close of market.

Teknova will host a webcast and conference call on Wednesday, March 15, 2023, beginning at 5:00 p.m. ET. Participants can access the live webcast on the Investor Relations section of the Teknova website and at this link: https://edge.media-server.com/mmc/p/6iefisfj. To receive a PIN number for dial in, participants can register for the webcast via this link: https://register.vevent.com/register/BI0f355397c6884c52ab3ec2b25cfbaea9. The webcast will be available for replay on the Company’s website approximately two hours after the event.

About Teknova   
Teknova makes solutions possible. Since 1996, Teknova has been innovating the manufacture of critical reagents for the life sciences industry to accelerate the discovery and development of novel therapies that will help people live longer, healthier lives. We offer fully customizable solutions for every stage of the workflow, supporting industry leaders in cell and gene therapy, molecular diagnostics, and synthetic biology. Our fast turnaround of high-quality agar plates, microbial culture media, buffers and reagents, and water helps our customers scale seamlessly from RUO to GMP. Headquartered in Hollister, California, with over 200,000 square feet of state-of-the-art facilities, Teknova’s modular manufacturing platform was designed by our team of scientists, engineers, and quality control experts to efficiently produce the foundational ingredients for the discovery and commercialization of novel therapies.

FAQ

What date will TKNO report its Q4 2022 financial results?

Alpha Teknova (TKNO) will report its Q4 2022 financial results on March 15, 2023.

What time is the TKNO conference call scheduled for March 15, 2023?

The TKNO conference call is scheduled for 5:00 p.m. ET on March 15, 2023.

Where can I access the TKNO financial results webcast?

The financial results webcast for TKNO can be accessed on the Investor Relations section of their website.

What services does Alpha Teknova provide?

Alpha Teknova provides critical reagents for life sciences, including solutions for cell and gene therapy, molecular diagnostics, and synthetic biology.

How long has Teknova been in operation?

Teknova has been innovating in the life sciences industry since 1996.